In general, the two mouse models (ob/ob and db/db) most commonly implemented in pre-clinical studies of type 2 diabetes/metabolic disturbances are characterized by monogenic mutations imparting dysfunction in the leptin signaling pathway [9–14]. Here, LEP is linked to type 2 diabetes mellitus.